A case-control association of RANTES (-28C >G) and CCR5-Delta32 polymorphisms with Parkinson's disease in Indians. (20th November 2020)

• Record Type: Journal Article
• Authors: Subramanian, Narayani; Ramanathan, Srishti; Paul, Solomon Franklin Durairaj; Venkatesan, Vettriselvi; Koshy, Teena
• Is Part Of: Neuroscience letters. Volume 739(2020)
• Publication Date: 2020-11-20
• Subjects: Parkinson's disease -- Chemokines -- Chemokine receptors -- Polymorphisms; Neurology -- Periodicals; Neurology -- Periodicals; Research -- Periodicals; Neurologie -- Périodiques; Neuroanatomie -- Périodiques; Neuropharmacologie -- Périodiques; Neurophysiologie -- Périodiques; Neurology; Periodicals; Electronic journals; 617.48
• DOI: 10.1016/j.neulet.2020.135404
• Languages: English
• ISSNs: 0304-3940

Abstract

Highlights: The association of RANTES (-28 C > G), RANTES (−403 A > G), MCP-1 (−2518 A > G, CCR2 (+190 G > A) and CCR5 (-Δ32) with PD risk in Indians was investigated. A negative association was demonstrated in the dominant model of RANTES (-28 C > G) polymorphism. A statistically significant higher frequency of the CCR5 heterozygous genotype WT/∆32 was observed in the controls. Allele combination of G-A-G-C of CCR2 (+190G > A), MCP-1 (-2518 A/G), RANTES (-403 A/G) and RANTES (-28 C/G) respectively had a risk association. Abstract: Recent studies have suggested that chemokines and their receptors are involved in several neurodegenerative disorders. Also, numerous lines of evidence have indicated that inflammatory processes are involved in the pathogenesis of Parkinson's disease (PD). We have examined whether single nucleotide polymorphisms at the genes encoding chemokines RANTES (-28 C > G), RANTES (-403 A > G) MCP-1 (-2518 A > G), and chemokine receptors CCR2 (+190 G > A) and CCR5 (-Δ32) were associated with sporadic PD risk in the Indian population. This pilot case-control association study included 97 PD patients and 100 control subjects, who were all genotyped with PCR-RFLP for the five polymorphisms. There was no statistically significant difference in the genotype frequencies between the cases and controls for the MCP1 (-2518 A > G), RANTES (-403 A > G) and CCR2 ( +190 G > A) polymorphisms. However, the results revealed a significant difference in the frequency of the heterozygous CG genotype for the RANTES (-28 C > G) polymorphism (OR = 0.49, p = 0.03) between the cases and controls. A negative association was demonstrated in the dominant model where, compared with the GG genotype, a higher frequency of the GC + CC genotype was observed in the controls. Also, a statistically significant higher frequency of the CCR5 heterozygous genotype WT/Δ32 in the controls was observed (OR = 0.31, p = 0.04). Combined genotype analysis revealed that the allele combination of G-A-G-C of CCR2 ( +190G > A), MCP-1 (-2518 A/G), RANTES (-403 A/G) and RANTES (-28 C/G) respectively had a risk association with PD (OR = 6.18, p = 0.005).